Our Experience With Micropulse Cyclophotocoagulation in the Therapy Of Glaucoma

Micropulse P3 Glaucoma Device Revolutionizes Cyclophotocoagulation

The newly patented MicroPulse P3 (MP3) device (Iridex) provides the surgeon a very safe and efficacious solution to treating glaucoma utilizing Iridex’s proprietary MicroPulse technology. While sharing similarities to G-Probe (Iridex), the primary advantage is the MP3 provides a kinder, gentler approach with identical efficacy yet improved safety profile.1 I have had the opportunity to be invol...

IRIDEX MicroPulse P3: innovative cyclophotocoagulation

Purpose: To present the new IRIDEX MicroPulse P3 (MP3) technology in patients with refractory glaucoma and our preliminary results at 1 week and 1 month postoperatively. Methods: IRIDEX MP3 laser cyclophotocoagulation was performed in 7 eyes of 7 patients under retrobulbar anaesthesia with lidocaine 2% in the operating room. Each eye received two treatments of 80-90s over the superior and infer...

Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma.

BACKGROUND Transscleral diode laser cyclophotocoagulation (TSCPC) is an established method of treatment for refractory glaucoma, but is associated with significant complications. This study evaluates the efficacy and safety of a new form of TSCPC using micropulse diode laser and trans-pars plana treatment with a novel contact probe. METHODS Prospective interventional case series of 40 eyes of...

Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study.

BACKGROUND The aim of this study was to compare the efficacy and safety of micropulse and continuous wave diode transscleral cyclophotocoagulation in refractory glaucoma. DESIGN Randomized, comparative, exploratory study in a tertiary hospital setting. PARTICIPANTS Patients with refractory, end-stage glaucoma. METHODS Forty-eight patients were randomized to either treatment. The intraocul...

Red Laser Cyclophotocoagulation for Treatment of Therapy-resistant Glaucoma